MPZL2
protein-codingmyelin protein zero like 2, the group of V-set domain containing|Ig-like cell adhesion molecule family
Gene summary
Thymus development depends on a complex series of interactions between thymocytes and the stromal component of the organ. Epithelial V-like antigen (EVA) is expressed in thymus epithelium and strongly downregulated by thymocyte developmental progression. This gene is expressed in the thymus and in several epithelial structures early in embryogenesis. It is highly homologous to the myelin protein zero and, in thymus-derived epithelial cell lines, is poorly soluble in nonionic detergents, strongly suggesting an association to the cytoskeleton. Its capacity to mediate cell adhesion through a homophilic interaction and its selective regulation by T cell maturation might imply the participation of EVA in the earliest phases of thymus organogenesis. The protein bears a characteristic V-type domain and two potential N-glycosylation sites in the extracellular domain; a putative serine phosphorylation site for casein kinase 2 is also present in the cytoplasmic tail. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
- EVA1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~11.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0019497
Submitter: ClinGen
MPZL2 was first associated with autosomal recessive nonsyndromic hearing loss as early as 2018 (Wesdorp et al., PMID: 29961571; Bademci et al., PMID: 29982980). At least three unique variants (nonsense and frameshift) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. Variants in this gene have been reported in at least 15 probands in 4 publications (PMID: 29961571, 29982980, 32203226, 33234333). Variants in this gene segregated with disease in at least 11 additional family members. More evidence is available in the literature, but the maximum score for genetic evidence has been reached. The mechanism of disease is suspected to be homozygous or compound heterozygous loss of function. This gene-disease association is supported by a mouse model and expression studies (PMID: 29961571, 29982980). In summary, there is strong evidence to support the relationship between MPZL2 and autosomal recessive nonsyndromic hearing loss. Three years must elapse from the first proposal of the association to reach a definitive classification without any valid contradictory evidence. We will re-evaluate this gene-disease relationship at that time to determine if an upgraded classification of definitive is warranted. This curation was approved by the Hearing Loss Gene Curation Expert Panel on 3/26/21 (SOP Version 8).
Inheritance Pattern: AR
Disease ID:MONDO:0029142
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0029142
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0019588
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0029142
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic
Intervention: Audiologic/Otolaryngologic
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MPZL2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005797.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 1 | 10 | |||
| missense | 1 | 43 | 5 | 1 | 50 | |
| nonsense | 5 | 5 | ||||
| start loss | 2 | 2 | ||||
| frameshift | 2 | 9 | 11 | |||
| splice donor/acceptor (+/-2bp) | 6 | 6 | ||||
| Total | 2 | 23 | 43 | 14 | 2 | 84 |
Highest pathogenic variant AF is 0.0006754061
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005788.1 | 5 | MANE Select | |
| Ensembl | ENSP00000278937.2 | 5 | MANE Select | |
| RefSeq | NP_658911.1 | 5 | Standard | |
| Ensembl | ENSP00000408362.2 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Differentiation of white and brown adipocyte
Biological Process
- homophilic cell adhesion via plasma membrane adhesion molecules
- anatomical structure morphogenesis
Molecular Function
- protein binding
Cellular Component
- cytoskeleton
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000278937
- Coding exons
- 5
- Length
- 11134
- Individuals with no LoFs
- 125280
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 466
- Defined
- 125746
- p
- 0.00185
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.480 | 147 | 132 | 1.12 | 0.00000778 | 1397 |
| Missense (PolyPhen) | 55 | 42.578 | 1.2917 | 446 | ||
| Synonymous | -0.290 | 49 | 46.5 | 1.05 | 0.00000253 | 431 |
| Loss of Function | -1.08 | 16 | 12.0 | 1.34 | 6.94e-7 | 118 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.0026 | 0.0026 | notable |
| Ashkenazi Jewish | 0.0038 | 0.0038 | notable |
| East Asian | 0.0058 | 0.0058 | notable |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.0017 | 0.0017 | notable |
| South Asian | 0.00085 | 0.00085 | rare |
| Other | 0.0015 | 0.0015 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Mediates homophilic cell-cell adhesion.;
Recessive Scores
- pRec
- 0.205
Intolerance Scores
- LoFtool
- 0.557
- RVIS EVS
- -0.05
- RVIS percentile EVS
- 50.01
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.132
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |